Abstract
Superiority and noninferiority (NI) trials are two common types of clinical trials. Superiority means, in layman’s language, that the test drug is better than the comparative drug (active comparator or active-control), whereas noninferiority suggests that the test drug may not be as good as the comparative drug, but the difference is not clinically significant. If a test drug is noninferior to an active-control, it must be at least superior to a placebo (Fig. 3.1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Readings and References
Brittain, E., Hu, Z.: Noninferiority trial design and analysis with an ordered three-level categorical endpoint. J. Biopharm. Stat. 19, 685–699 (2009)
Chan, I.S.F.: Power and sample size determination for noninferiority trials using an exact method. J. Biopharm. Stat. 12(4), 457–469 (2002)
Chang, M.: Multiple-arm superiority and noninferiority designs with various endpoints. Pharm. Stat. 6, 43–52 (2007a)
Chang, M.: Adaptive Design Theory and Implementation Using SAS and R. Chapman & Hall/CRC, Boca Raton (2007b)
Chang, M.: Monte Carlo Simulation for the Pharmaceutical Industry. Chapman and Hall/CRC, Raton (2010)
CHMP: Points to consider on switching between superiority and noninferiority. Br. J. Clin. Pharm. 52, 223–228 (2001)
CHMP: Guideline on the choice of the noninferiority margin, EMEA/EWP/2158/99. London, July 27, 2005 (2005)
Chow, S.C., Shao, J.: On noninferiority margin and statistical tests in active control trials. Stat. Med. 25, 1101–1113 (2005)
Cook, R.J., Lee, K.A., Li, H.: Noninferiority trial design for recurrent events. Stat. Med. 26, 4563–4577 (2007)
CPMP: Points to consider on switching between superiority and non-inferiority. www.ema. europa.eu (2000). Accessed 18 May 2010
D’Agostino, R.B.: Editoral, noninferiority trials: Advances in concepts and methodology. Stat. Med. 22, 165–167 (2003)
D’Agostino, R.B., Massaro, J.M., Sullivan, L.M.: Noninferiority trials: Design concepts and issues-the encounters of academic consultants in statistics. Stat. Med. 22, 169–186 (2003)
Dunnett, C.W., Gent, M.: An alternative to the use of two-sided tests in clinical trials. Stat. Med. 15, 1729–1738 (1976)
Dunnett, C.W., Gent, M.: Significant testing to establish equivalence between treatments with special reference to data in the form of 2 ×2 tables. Biometrics 33, 593–602 (1977)
Ellenberg, S.S., Temple, R.: Placebo-controlled trials and active controlled trials in the evaluation of new treatment. Part 2: Practical issues and specific cases. Ann. Intern. Med. 133, 464–470 (2000)
Farrington, C.P., Manning, G.: Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat. Med. 9, 1447–1454 (1990)
FDA: International Conference on Harmonisation. Statistical Principles for Clinical Trials (ICH E 9). Food and Drug Administration, Department of Health and Human Services, Washingtom (1998)
FDA: Guidance for Industry Non-Inferiority Clinical Trials (draft). Food and Drug Administration, Department of Health and Human Services, Washingtom (2010)
Fleming, T.R.: Current issues in noninferiority trials. Stat. Med. 27, 317–332 (2008)
Hung, H.M., Wang, S.J., O’Neill, R.T.: Issues with statistical risks for testing methods in noninferiority trial without a placebo arm. J. Biopharm. Stat. 17(2), 201–213 (2007)
Ioannidis, J.P.A.: Why most published research findings are false. PLoS Med. 2(8), e124 (2005)
Kieser, M., Friede, T.: Planning and analysis of three-arm non-inferiority trials with binary endpoints. Stat. Med. 26, 253–273 (2007)
Liu, J.P., Hsueh, H.M., Hsieh, E., Chen, J.J.: Tests for equivalence or noninferiority for paired binary data. Stat. Med. 21, 231–245 (2002)
Koch, G.G.: Commentory, comments on ‘Current issues in noninferiority trials’. Stat. Med. 27, 333–342 (2008)
Kong, L., Kohberger, R.C., Koch, G.G.: Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: An example from vaccine development trials. J. Biopharm. Stat. 14, 893–907 (2004)
Koyama, T., Westfall, P.H.: Decision-theoretic views on simultaneous testing of superiority and noninferiority. J. Biopharm. Stat. 15, 943–955 (2005)
Lu, Y., Jin, H., Genant, H.K.: On the noninferiority of a diagnostic test based on paired observations. Stat. Med. 22, 3029–3044 (2003)
Morikawa, T., Yoshida, M.: A useful testing strategy in phase III trials: Combined test of superiority and test of equivalence. J. Biopharm. Stat. 5, 297–306 (1995)
Nam, J.: Establishing equivalence of two treatments and sample size requirements in matched-pairs design. Biometrics 53, 1422–1430 (1997)
Nam, J., Kwon, D.: Noninferiority tests for clustered matched-pair data. Stat. Med. 28, 1668–1679 (2009)
Ng, T.H.: Issues of simultaneous tests for noninferiority and superiority, with discussions. J. Biopharm. Stat. 13, 629–639 (2003)
Ng, T.H.: Simultaneous testing of noninferiority and superiority increases the false discovery rate. J. Biopharm. Stat. 17, 259–264 (2007)
PAREXEL: Parexel’s Bio/Pharmaceutical R&D Statistical Sourcebook 2007/2008. PAREXEL, Waltham (2008)
Pearlman, J.B.: The commercialization of medicine. http://www.google.com (2007). Accessed 10 Sep 2009
Pigeot, I., Schäfer, J., Röhmel, J., Hauschke, D.: Assessing noninferiority of a new treatment in a three-arm clinical trial including a placebo. Stat. Med. 22, 883–899 (2003)
Rothmann, M., Li, N., Chen, G., Chi1, G.Y.H., Temple, R., Tsou, H.H.: Design and analysis of noninferiority mortality trials in oncology. Stat. Med. 22, 239–264 (2003)
Shao, J.: Mathematical Statistics. Springer, New York, NY (2003)
Sidik, K.: Exact unconditional tests for testing noninferiority in matched-pairs design. Stat. Med. 22, 265–278 (2003)
Siqueira, A.L., Whitehead, A., Todd, S.: Active-control trials with binary data: A comparison of methods for testing superiority or noninferiority using the odds ratio, with comments. Stat. Med. 27, 353–370 (2008)
Snapinn, S., Jiang, Q.: Correction. Stat. Med. 27, 4855–4856 (2008)
Tang, M.L., Tang, N.S.: Tests of noninferiority via rate difference for three-arm clinical trials with placebo. J. Biopharm. Stat. 14, 337–347 (2004)
Tango, T.: Equivalence test and confidence interval for the difference in proportions for the paired-sample design. Stat. Med. 17, 891–908 (1998)
Temple, R.: Active control noninferiority studies: Theory, assay sensitivity, choice of margin. FDA presentation. www.FDA.gov (2002). Accessed 19 Feb 2002
Temple, R., Ellenberg, S.S.: Placebo-controlled trials and active-controlled trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Ann. Intern. Med. 133, 455–463 (2000)
Tsong, Y., Chen, W.J.: Noninferiority testing beyond simple two-sample comparison. J. Biopharm. Stat. 17, 289–308 (2007)
Wang, Y.C., Chen, G., Chi, G.Y.H.: A ratio test in active control non-inferiority trials with time-to-event endpoint. J. Biopharm. Stat. 16, 151–164 (2006)
Wang, S.J., Hung, H.M., Tsong, Y., Cui, L.: Group sequential test strategies for superiority and noninferiority hypotheses in active controlled clinical trials. Stat. Med. 20, 1903–1912 (2001)
Wiens, B.L., Heyes, J.F.: Testing for interactions in studies of noninferiority. J. Biopharm. Stat. 13, 103–115 (2003)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Chang, M. (2011). Noninferiority Trial Design. In: Modern Issues and Methods in Biostatistics. Statistics for Biology and Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9842-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9842-2_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9841-5
Online ISBN: 978-1-4419-9842-2
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)